Search results

Filter

Filetype

Your search for "*" yielded 564162 hits

Lund Stem Cell Center joins 4.5 million euro Horizon Europe doctoral network to advance human-relevant brain models beyond animal testing

Researchers at the Lund Stem Cell Center and Faculty of Medicine at Lund University are part of a new €4.5 million European doctoral training network that aims to improve how complex brain disorders are studied. The initiative will develop advanced models of the human brain, reducing reliance on animal testing and strengthening the relevance of preclinical research for patients. The programme, VIS

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-45-million-euro-horizon-europe-doctoral-network-advance-human-relevant - 2026-08-17

EIC Transition grant to advance OssiGel for bone repair

A consortium led by Paul Bourgine has been awarded EIC Transition grant with 2,5 million Euro over three years. This covers activities that are typically hard to finance - researchers refer to the famous « valley of death » illustrating the difficulty of translating promising basic research into human clinical practice. What is your project about?  "Our project is entitled DENOVOSS which stands fo

https://www.stemcellcenter.lu.se/article/eic-transition-grant-advance-ossigel-bone-repair - 2026-08-17

Malin Parmar Selected as a Candidate for Vice President of the ISSCR

Malin Parmar, Professor of Cellular Neuroscience at Lund University and Director of the Lund Stem Cell Center, has been selected as a candidate for Vice President of the International Society for Stem Cell Research (ISSCR). The ISSCR is a leading global society for stem cell research, bringing together scientists, clinicians, industry representatives and policy experts from across the field and th

https://www.stemcellcenter.lu.se/article/malin-parmar-selected-candidate-vice-president-isscr - 2026-08-17

Cancerfonden grants support early-career researchers in exploring new approaches to understanding and treating cancer

For many cancer patients, successful treatment depends on whether the disease is detected early or responds to existing therapies. With new grants from the Swedish Cancer Society (Cancerfonden), three postdoctoral researchers at Lund University’s Lund Stem Cell Center will investigate new drivers of cancer development and how the immune system can be more effectively mobilised against tumors. In M

https://www.stemcellcenter.lu.se/article/cancerfonden-grants-support-early-career-researchers-exploring-new-approaches-understanding-and - 2026-08-17

UniStem Day 2026: Opening a door to a life in science

What happens when 200 high school students step inside a research center for a full day of science? Curiosity ignites, questions multiply, and for many, new futures begin to feel possible. At the end of March, Lund Stem Cell Center welcomed students from Lars Erik Larsson gymnasiet in Lund, Söderslättsgymnasiet in Trelleborg, and Malmö Borgarskola, Malmö Latinskola, and Sjölins Gymnasium in Malmö

https://www.stemcellcenter.lu.se/article/unistem-day-2026-opening-door-life-science - 2026-08-17

Professor Malin Parmar elected Vice President of the International Society for Stem Cell Research

Malin Parmar, Professor of Cellular Neuroscience at Lund University and Director of the Lund Stem Cell Center, has been elected Vice President of the International Society for Stem Cell Research, the world’s leading organisation for stem cell science and regenerative medicine. The International Society for Stem Cell Research (ISSCR) is an independent, global, nonprofit organization that brings tog

https://www.stemcellcenter.lu.se/article/professor-malin-parmar-elected-vice-president-international-society-stem-cell-research - 2026-08-17

Global study advances harmonised quality control for stem cell‑based therapies

A large international collaboration involving researchers from Lund University’s Lund Stem Cell Center has taken an important step toward making induced pluripotent stem cell (iPSC)–based therapies more globally accessible. Published in Stem Cell Reports, the study presents the first data‑driven international benchmarking of key quality control assays, showing how standardized methods can reduce v

https://www.stemcellcenter.lu.se/article/global-study-advances-harmonised-quality-control-stem-cell-based-therapies - 2026-08-17

What Does AI Really Cost Biomedical Research?

Artificial intelligence (AI) is becoming a routine tool in biomedical research, helping scientists analyse data, understand diseases and develop new treatments. But as AI models grow larger and more complex, they also rely on increasing amounts of energy, data storage and computing power. These environmental impacts are rarely visible to the researchers using the technology. As part of this year’s

https://www.stemcellcenter.lu.se/article/what-does-ai-really-cost-biomedical-research - 2026-08-17

New immunotherapy initiative aims to bring research closer to the clinic and opens new tenure‑track positions

A new joint initiative in immunotherapy between Lund University and Skåne University Hospital, Sweden, brings researchers, clinicians and engineers together to shorten the path from research to patient benefit. The initiative is accompanied by the recruitment of three new tenure‑track Assistant Professors in immunotherapy through the Lund University Programme for Global Excellence. The initiative

https://www.stemcellcenter.lu.se/article/new-immunotherapy-initiative-aims-bring-research-closer-clinic-and-opens-new-tenure-track-positions - 2026-08-17

Prestigious international award for Martin L. Olsson

Martin L. Olsson has received the International Society for Blood Transfusion (ISBT) Presidential Award, the highest international honour in transfusion medicine. The award is presented every two years to a researcher who has made outstanding contributions to transfusion medicine. Martin L. Olsson is recognised for translational research on red blood cells, following 35 years of work mapping the g

https://www.stemcellcenter.lu.se/article/prestigious-international-award-martin-l-olsson - 2026-08-17

81 million SEK drives new international effort to study aging and epigenetic changes in Parkinson’s Disease

Every person ages, yet only some develop Parkinson’s Disease, and scientists still don’t know why. A new international effort involving a research team from Lund University aims to uncover what makes certain aging brains more vulnerable than others, focusing on the epigenetic changes that accompany growing older. Their work is supported by a new 81 million SEK grant from the Aligning Science Acros

https://www.stemcellcenter.lu.se/article/81-million-sek-drives-new-international-effort-study-aging-and-epigenetic-changes-parkinsons-disease - 2026-08-17

Early-life B cells can drive leukemia later in life

Researchers at the Lund Stem Cell Center, Lund University, have discovered that a population of B cells formed shortly after birth store long-term immune memory and, in mice, can give rise to leukemia much later in life. Published in Cell Reports, the findings reveal how immune events at the very beginning of life can leave lasting biological imprints, linking early development to disease in old a

https://www.stemcellcenter.lu.se/article/early-life-b-cells-can-drive-leukemia-later-life - 2026-08-17

Lund Stem Cell Center joins BEYOND European postdoctoral programme in advanced therapies

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-08-17

STEM-PD enters a new chapter as Cellular Intelligence acquires global rights to advance the stem cell therapy for Parkinson's Disease

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-08-17

A training ground for cell and gene therapies: New pre-GMP facility aims to smooth the path from idea to patient

When research findings are ready to make the leap from the lab to the patient, the requirements become much stricter. That is precisely where many promising projects start to falter. “We want to be the bridge between research and the patient, so that promising projects don’t get stuck in that difficult transition,” says Sara Nolbrant, director of the new pre-GMP facility. And with that, she disapp

https://www.stemcellcenter.lu.se/article/training-ground-cell-and-gene-therapies-new-pre-gmp-facility-aims-smooth-path-idea-patient - 2026-08-17

Lund Stem Cell Center welcomes four new research group leaders

Lund Stem Cell Center continues to grow as a leading hub for interdisciplinary stem cell research, welcoming four new principal investigators into its research community. Together, they bring specialised expertise spanning molecular and cell biology, immunology and bioengineering, further strengthening the Center’s scientific scope and possibilities for collaboration. How cells protect their DNA,

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-welcomes-four-new-research-group-leaders - 2026-08-17

STEM-PD announces first in-human clinical trial results for Parkinson’s disease cell therapy

A landmark study led from Lund, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow up. The results are published in Nature Medicine. In Parkinson’s disease, patients lose nerve cells in

https://www.stemcellcenter.lu.se/article/stem-pd-announces-first-human-clinical-trial-results-parkinsons-disease-cell-therapy - 2026-08-17

Welcome two new Principal Investigators to Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Principal Investigators Daniella Ottosson and Charlotta Böiers have been accepted to join Lund Stem Cell Center.A warm welcome to the Ottosson and Böiers groups. To learn more about their research, the following Stem Cell Talks have been scheduled: Wednesday 25th September: Principal Investigator Daniella Ottosson. De

https://www.stemcellcenter.lu.se/article/welcome-two-new-principal-investigators-lund-stem-cell-center - 2026-08-17

CMES Pınar Dinç is presenting 'Fake news? Understanding the conflict and forest fire nexus through media breakdown’

The workshop is called: Unpacking ‘the Opposition’ in undemocratic regimes: The Role, Transformation and Challenges of the Oppositional Actors in Turkey and beyond The purpose of this workshop is to initiate a debate on the opposition in Turkey and contribute to the theorization of the role, transformation, mobilization strategies and different forms of the opposition in undemocratic regimes.  The

https://www.cmes.lu.se/article/cmes-pinar-dinc-presenting-fake-news-understanding-conflict-and-forest-fire-nexus-through-media - 2026-08-17